Status:
COMPLETED
Intensity-Modulated Radiation Therapy (IMRT) in the Treatment of Non-Anaplastic Non-Medullary Thyroid Cancer
Lead Sponsor:
Memorial Sloan Kettering Cancer Center
Conditions:
Thyroid Cancer
Eligibility:
All Genders
18+ years
Phase:
PHASE2
Brief Summary
The purpose of this Phase 2 study is to find out what effect, good and/or bad, external beam radiation therapy, has on the patient and their thyroid cancer where surgery is not an option or where desp...
Eligibility Criteria
Inclusion
- Pathologically confirmed diagnosis of non-anaplastic non-medullary thyroid cancer that is either grossly recurrent after surgery or unresectable with or without metastatic disease.
- Age ≥18 years
- Karnofsky performance status ≥70%
- Men and women of childbearing potential must be willing to consent to using effective contraception while on treatment and for at least 3 months after treatment.
- Patients must have ability to understand and the willingness to sign a written informed consent document.
Exclusion
- Women who are pregnant or lactating
- Inability to comply with study and/or follow-up procedures
Key Trial Info
Start Date :
June 13 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 4 2021
Estimated Enrollment :
27 Patients enrolled
Trial Details
Trial ID
NCT01882816
Start Date
June 13 2013
End Date
November 4 2021
Last Update
December 29 2022
Active Locations (6)
Enter a location and click search to find clinical trials sorted by distance.
1
Memorial Sloan Kettering Basking Ridge
Basking Ridge, New Jersey, United States
2
Memorial Sloan Kettering Monmouth
Middletown, New Jersey, United States, 07748
3
Memorial Sloan Kettering Commack
Commack, New York, United States, 11725
4
Memorial Sloan Kettering Westchester
Harrison, New York, United States, 10604